Opens in a new tab

Edwards Lifesciences v Meril (CFI, 20 December 2024)

Date20 December 2024
CourtCFI
DivisionMunich (DE) Local Division
Type of actionInfringement Action
Registry referenceACT_597277/2023 · ORD_598551/2023
PartiesEdwards Lifesciences Corporation v. Meril GmbH, Meril Life Sciences Pvt. Ltd., Meril Italy S.r.l.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

In an order of 20 December 2024 following the interim conference (UPC_CFI_501/2023), the Munich Local Division, acting through its judge-rapporteur, allowed Edwards Lifesciences to extend its infringement action on EP 3 669 828 to Romania and allowed the Meril companies to extend their counterclaim for revocation accordingly. More significantly, it held that the claimant’s specification of the information the defendants are to provide is not an amendment of the case under Rule 263 but falls under Rule 13. The order also set the value of the dispute at €16 million and organised the oral hearing of 11 February 2025.

Question

Do adding a country and specifying the content of a request for information require leave under Rule 263, and on what basis?

Decision

Not every new argument amounts to an amendment of the case: there is one only where the nature or scope of the dispute changes. Changes confined to how information is to be provided fall under Rule 13, read with recital 7 of the preamble requiring parties to present their case as early as possible. Having been filed well before the hearing, they were admitted, whether the information is actually owed being left open. As Romania was mentioned in neither the statement of claim nor the counterclaim, and both parties now wished to include it, leave was granted on both sides. The Division also invited the claimant to clarify the order in which its auxiliary requests to amend the patent, which split into two lines, should be considered, since the court cannot choose on the patentee’s behalf. Requests to hear party experts and to appoint a court expert were rejected for now.

Key points for practice

Provisions applied

Rules of Procedure
Rules 13, 105.5 and 263, recital 7 of the preamble
Case law cited
Court of Appeal, order of 21 November 2024, UPC_CoA_456/2024, Heraeus Electronics v Vibrantz, Munich Local Division, 2 December 2024

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Decisions in the same proceedings

Going further

Lexicon: Patent infringement action.

Publications by Matthieu Dhenne: Pleading the Long Arm: What a UPC Statement of Claim Must Carry Beyond Jurisdiction (Kluwer Patent Blog).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Infringement Action
Outcome (Dhenne Avocats summary)
La précision des informations demandées aux défenderesses relève de la règle 13 et non de la règle 263, faute de modifier la nature ou l’étendue du litige. L’extension à la Roumanie de l’action et de la demande reconventionnelle est autorisée, les deux parties la souhaitant.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 3 669 828
Prosthetic heart valve
recorded proprietor: Edwards Lifesciences Corp
Mentioned in the analysis (role not qualified)
Also mentioned in 11 other decision(s): Edwards Lifesciences v Meril (CFI, 4 April 2025) · Edwards Lifesciences v Meril (CFI, 12 August 2026) · Edwards Lifesciences v Meril (CFI, 26 June 2026) · Edwards Lifesciences v Meril (CFI, 17 October 2025) · Edwards Lifesciences v Meril (CFI, 3 June 2025) · Edwards Lifesciences v Meril (CFI, 14 April 2025) · Edwards Lifesciences v Meril (CFI, ORD_60824/2024, 9 April 2025) · Edwards Lifesciences v Meril (CFI, 5 February 2025)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.